Trial | NCT01203540  Report issue

Official Title

Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    21
Multicentre, Double blind, Randomized, Comparative Study(comparing N-acetyl-aspartyl-glutamic acid(NAAGA) in Abak preservative free device versus SALINE in Abak preservative free device.

Evaluation of the effects and safety of NAABAK® through inflammation markers and symptoms in patients with allergic conjunctivitis and dry eye syndrome after 3 months treatment.

The patients will attend 4 visits.
Study Started
Oct 31
2010
Study Completion
Jan 31
2011
Last Update
Jan 31
2012
Estimate

Drug NAABAK eyedrops

Drug Saline eyedrops

Naaga in ABAK system Experimental

Saline solution Placebo Comparator

Criteria 

Inclusion Criteria:

Age ≥ 20 years old
Patients with dry eye syndrome in allergic conjunctivitis

Exclusion Criteria:

Severe dry eye syndrome
Severe ocular pathology
No Results Posted